Double shock strategy for cardiac arrest put to the test in pilot trial

NCT ID NCT06447805

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested whether using two defibrillators early, instead of one, is feasible and safe for people whose hearts stop outside a hospital and don't respond to the first shock. Researchers enrolled 40 adults with a shockable heart rhythm. The goal was to see if emergency crews could follow the double-shock plan reliably and without harming patients. Results will help design a larger study to see if this approach saves more lives.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Double sequential defibrillation (using two defibrillators)
What this could lead to
If this approach proves feasible and safe, it could lead to a larger study that may improve survival for people whose heart rhythm doesn't respond to standard defibrillation.
What could go wrong
This is a small pilot study with only 40 participants, focused on feasibility, not on proving the treatment works. The results may not apply to all cardiac arrest patients, and there are risks like defibrillator malfunction or delays in CPR.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC ARREST are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Emergency medical services Region Halland

    Halmstad, Halland County, 30238, Sweden

  • Sahlgrenska Universitetssjukhuset, Ambulans och Prehospital Akutsjukvård

    Gothenburg, Västra Götalandsregionen, 411 04, Sweden

  • Sjukhusen i väster, ambulanssjukvården Alingsås/Lerum

    Alingsås, Västra Götalandsregionen, 441 39, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.